Case report: Etizolam and its major metabolites in two unnatural death cases

Forensic Science International

Volumn 182, Issue 1-3, 2008, Pages

  Nakamae, Takuma ^a,c   Shinozuka, Tatsuo ^b,c   Sasaki, Chizuko ^c   Ogamo, Akira ^a   Murakami Hashimoto, Chikako ^c   Irie, Wataru ^c   Terada, Masaru ^d   Nakamura, Shigeki ^c   Furukawa, Masataka ^c   Kurihara, Katsuyoshi ^c  

^a INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b YOKOHAMA COLLEGE OF PHARMACY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Etizolam; Ion trap GC MS MS; Metabolite; Solid phase extraction

Indexed keywords

8 HYDROXYETIZOLAM; ALPHA HYDROXYETIZOLAM; DRUG METABOLITE; ETIZOLAM; FLUDIAZEPAM; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG ISOLATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; ION TRAP MASS SPECTROMETRY; MALE; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; SUICIDE; TANDEM MASS SPECTROMETRY;

EID: 56349153580     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2008.08.012     Document Type: Article

References (18)

1. Casacchia M., Bolino F., and Ecari U. Etizolam in the treatment of generalized anxiety disorder. A double-blind study versus placebo. Curr. Med. Res. Opin. 12 (1990) 215-223
2. Savoldi F., Somenzini G., and Ecari U. Etizolam vs. placebo in the treatment of panic disorder with agoraphobia: a double-blind study. Curr. Med. Res. Opin. 12 (1990) 185-190
3. Astellas Pharma, ALMANAC 2005/Medical Care & the Pharmaceutical Industry, 2005.
4. ® Interview Form, 2006.
5. Fracasso C., Confalonieri S., Garattini S., and Caccia S. Single and multiple dose pharmacokinetics of etizolam in healthy subjects. Eur. J. Clin. Pharmacol. 40 (1991) 181-185
6. National Research Institute of Police Science, Annual case reports of drug and toxic poisoning in Japan, 47 (2005).
7. Tsumagari T., Nakajima A., Fukuda T., Shuto S., Kenjo T., Morimoto Y., and Takigawa Y. Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo [3,4-c]thieno[2,3-e][1,4]diazepine(Y-7131), a new anti-anxiety drug. Arzneimittelforschung 28 (1978) 1158-1164
8. Nakagawa K., and Sarai K. The usage experience of Depas (Etizolam) the psychiatry region. Rinsyo to Shinyaku 23 (1986) 1377-1394 (in Japanese)
9. Rumack B.H., and Spoerke D.G. Benzodiazepines. Poisondexr Information System vol. 83 (1996), Micromedex, Inc., Colorado
10. Soo V.A., Bergert R.J., and Deutsch D.G. Screening and quantification of hypnotic sedatives in serum by capillary gas chromatography with a nitrogen-phosphorus detector, and confirmation by capillary gas chromatography-mass spectrometry. Clin. Chem. 32 (1986) 325-328
11. Inoue H., Maeno Y., Iwasa M., Matoba R., and Nagao M. Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. Forensic Sci. Int. 113 (2000) 367-373
12. Tanaka E., Terada M., Misawa S., and Wakasugi C. Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel. J. Chromatogr. B: Biomed. Appl. 682 (1996) 173-178
13. ® for benzodiazepines: urine analysis of the dose of therapeutic cases. J. Anal. Toxicol. 2 (2005) 539-543
14. Hama K., Matsubara K., Akane A., Maseda C., Tanabe K., and Fukui Y. Analysis of etizolam, triazolam, nitrazepam and maprotiline in autopsy materials by high-performance liquid chromatography and gas chromatography. Nihon Hoigaku Zasshi 41 (1987) 45-51 (in Japanese)
15. Hayashida M., Nihira M., Hayakawa H., Sai H., and Ohno Y. An autopsy case administered four species of benzodiazepines identified by LC-ESI-MS. Jpn. J. Forensic Toxicol. 23 (2005) 134-135
16. Suzuki Y., Kawashima Y., Shioiri T., and Someya T. Effects of concomitant fluvoxamine on the plasma concentration of etizolam in Japanese psychiatric patients: wide interindividual variation in the drug interaction. Ther. Drug Monit. 26 (2004) 638-642
17. Kondo S., Fukasawa T., Yasui-Furukori N., Aoshima T., Suzuki A., Inoue Y., Tateishi T., and Otani K. Induction of the metabolism of etizolam by carbamazepine in humans. Eur. J. Clin. Pharmacol. 61 (2005) 185-188
18. Araki K., Yasui-Furukori N., Fukasawa T., Aoshima T., Suzuki A., Inoue Y., Tateishi T., and Otani K. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism. Eur. J. Clin. Pharmacol. 60 (2004) 427-430